NCT04585191Completed
Reducing Treatment Risk in Older Adults With Diabetes
Reducing Treatment Risk in Older Patients With Diabetes: Comparative Effectiveness of Academic Detailing With and Without Pre-Visit Patient Preparation
Source: ClinicalTrials.gov · Last updated 21 Mar 2025
Brief summary (registry, in English)
This study will evaluate the impact of academic detailing (evidence-based provider education) with or without patient pre-visit preparation (elicitation of values and preferences) on safe insulin de-prescribing among older patients with type 2 diabetes at risk for hypoglycemia. The hypothesis is that patients who are well-prepared for their primary care visit will engage in more informed discussions with their providers regarding re-evaluation of current treatment regimens. In clinically appropriate cases, these more effective discussions will result in safe de-prescribing and fewer future episodes of hypoglycemia.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 450 (actual)
- First submitted
- 28 Sept 2020
- Start date
- 2 Nov 2020
- Primary completion date
- 30 Mar 2024
- Lead sponsor
- Kaiser Permanente
- Diseases
- Type 2 diabetes
- NCT number
- NCT04585191
What you commit to
- Study type: Interventional
- Participants enrolled: 450
- From 2 Nov 2020 to the primary completion date, 30 Mar 2024
- 4 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Given the requirements of this funding mechanism, we will not be able to develop new patient materials in languages other than English, and patients unable to communicate in English will be excluded.
- Similarly, patients unable to provide informed consent and/or participate in informed decision making due to cognitive or communication-related deficits will be excluded.
- Excluded by their primary care provider
Who the study is looking for
- age ≥ 75 years
- type 2 diabetes with last measured Hemoglobin A1c (HbA1c) ≤ 8.0%
- currently prescribed insulin and/or sulfonylureas (SUs)
- Kaiser Permanente Northern California member
Age in the registry: 75 years to - · Sex: All · Does not accept healthy volunteers
Sites (4)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Kaiser Permanente South San Francisco Coordinator of this site? Confirm its status | San Francisco | United States | Unknown status |
| Kaiser Permanente Northern California Coordinator of this site? Confirm its status | San Leandro | United States | Unknown status |
| Kaiser Permanente - Union City Coordinator of this site? Confirm its status | Union City | United States | Unknown status |
| Kaiser Permanente-Vallejo Coordinator of this site? Confirm its status | Vallejo | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.